ストックスクリーナーアプリを入手
0.3138
17.77%
-0.0678
前日終値:
$0.3816
開ける：
$0.3702
24時間の取引高:
4.12M
Relative Volume:
14.51
時価総額：
$31.65M
収益：
$30.31M
当期純損益:
$-22.84M
株価収益率:
-0.6973
EPS:
-0.45
ネットキャッシュフロー:
$-22.61M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
-51.72%
1年 パフォーマンス:
-72.95%
1日の値動き範囲:
$0.3138
$0.40
1週間の範囲:
$0.3138
$0.40
52週間の値動き範囲:
$0.252
$1.20
Enzo Biochem Inc Stock (ENZ) Company Profile
ENZ を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ENZ
Enzo Biochem Inc
|
0.3138 | 31.65M | 30.31M | -22.84M | -22.61M | -0.45 |
|
TMO
Thermo Fisher Scientific Inc
|
426.82 | 158.06B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
198.95 | 142.87B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
534.47 | 43.87B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
120.63 | 33.87B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
160.29 | 28.10B | 15.50B | 1.33B | 2.16B | 7.34 |
Enzo Biochem Inc Stock (ENZ) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2011-10-18 | 繰り返されました | Rodman & Renshaw | Mkt Outperform |
| 2009-09-23 | 開始されました | Rodman & Renshaw | Mkt Outperform |
| 2007-09-13 | 開始されました | Lazard Capital | Buy |
Enzo Biochem Inc (ENZ) 最新ニュース
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: HSON, ENZB, and BRZH - The Malaysian Reserve
Investigation into Hudson Global, Enzo Biochem, and Breeze Holdings mergers by Monteverde & Associates PC. - AInvest
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: DNOW, ENZB, SPTN, and BASE - cnhinews.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CARM, ENZB, GNTY on Behalf of Shareholders - MarketScreener
Battery Ventures to buy Enzo Biochem for $0.70 per share in all cash-deal - MSN
Enzo Biochem to be acquired for $0.70/share in Battery Ventures deal | ENZ SEC FilingForm 8-K - Stock Titan
ENZ to be Acquired for $0.70 Cash in Battery Ventures Deal | ENZ SEC FilingForm DEFA14A - Stock Titan
Enzo Biochem: Fiscal Q3 Earnings Snapshot - New Haven Register
Enzo Biochem Reports Revenue Decline and Net Loss - TipRanks
Enzo Biochem Explores Sale Options as Q3 Revenue Drops 20%, Settles Cyber Incident for $7.5M - Stock Titan
Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results - GlobeNewswire
ENZO BIOCHEM INC SEC 10-Q Report - TradingView
Enzo Biochem (NYSE:ENZ) Earns Hold Rating from Analysts at StockNews.com - Defense World
Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com - Defense World
Deadline to claim up to $10K from Enzo Biochem data breach settlement - Fingerlakes1.com
Press Release Distribution & PR Platform - ACCESS Newswire
Enzo Biochem (NYSE:ENZ) Coverage Initiated at StockNews.com - Defense World
Recent Insider Activity Suggests Potential Gains for Enzo Biochem, Inc (ENZ) - knoxdaily.com
Enzo Biochem Announces Review of Strategic Alternatives - marketscreener.com
Enzo Biochem, Inc (ENZ)’s stock price range in the last year - uspostnews.com
Enzo Biochem, Inc. Announces Review of Strategic - GlobeNewswire
Enzo Biochem Announces Review Of Strategic Alternatives After Receiving Multiple Inquiries Regarding A Potential Transaction - marketscreener.com
Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple ... - Bluefield Daily Telegraph
Enzo Biochem Launches Strategic Review: Multiple Buyers Eye Global Life Sciences Operations - Stock Titan
Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple Inquiries Regarding a Potential Transaction - Yahoo Finance
Enzo Biochem transitions to OTCQX market By Investing.com - Investing.com South Africa
Enzo Biochem transitions to OTCQX market - Investing.com
OTC Markets Group welcomes addition of Enzo Biochem to OTCQX - Proactive Investors
OTC Markets Group Welcomes Enzo Biochem, Inc. to OTCQX | OTCM St - GuruFocus
OTC Markets Group Welcomes Enzo Biochem, Inc. to OTCQX | OTCM Stock News - GuruFocus
OTC Markets Group Welcomes Enzo Biochem, Inc. to OTCQX - The Manila Times
Enzo Biochem Makes Strategic Move to OTCQX Market: Cost Savings While Maintaining Investor Access - Stock Titan
The Zacks Analyst Blog AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment - Yahoo Finance
Top Research Reports for AbbVie, TJX & Charles Schwab - Yahoo Finance
Enzo Biochem (NYSE:ENZ) Now Covered by StockNews.com - Defense World
Market Resilience: Enzo Biochem, Inc (ENZ) Finishes Weak at 0.29, Down -8.98 - DWinneX
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Virtu Financial LLC Takes $35,000 Position in Enzo Biochem, Inc. (NYSE:ENZ) - Defense World
Enzo Biochem stock hits 52-week low at $0.33 amid market challenges - Investing.com Australia
Enzo Biochem stock hits 52-week low at $0.33 amid market challenges By Investing.com - Investing.com South Africa
Enzo Biochem to Delist from NYSE, Move to OTCQX - TipRanks
StockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ) - Defense World
Enzo Biochem to delist from NYSE, move to OTCQX market - Investing.com India
Enzo Biochem to delist from NYSE, move to OTCQX market By Investing.com - Investing.com South Africa
Enzo Biochem to voluntarily delist from NYSE and transfer trading of shares to OTCQX; shares fall - MSN
Enzo Biochem (ENZ) to Voluntarily Delist from NYSE, Move to OTCQ - GuruFocus
Enzo Biochem Inc (ENZ) 財務データ
収益
当期純利益
現金流量
EPS
11.70%
0.02%
大文字化:
|
ボリューム (24 時間):